X0306
4
2019-01-15
0
0001560258
electroCore, Inc.
ECOR
0001737616
Errico Joseph P
150 ALLEN ROAD, SUITE 201
BASKING RIDGE
NJ
07920
1
1
1
0
See Remarks
Common Stock
2019-01-15
4
S
0
22349
4.90
D
610000
D
Common Stock
2019-01-16
4
S
0
19810
4.89
D
590190
D
Common Stock
2019-01-17
4
S
0
7841
4.84
D
582349
D
Common Stock
69444
I
Via Errico 2010 Dynasty Trust
Common Stock
55729
I
Via children
Common Stock
111318
I
Via Core Ventures 2010, LLC
Common Stock
50498
I
Via 2010 Core Investment Partners, LLC
Common Stock
419789
I
Via Core Ventures II, LLC
Common Stock
15576
I
Via Core Ventures IV, LLC
Common Stock
25473
I
Via ECNG, LLC
Common Stock
382607
I
Via NeuroCore Investment Partners, LLC
These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $5.11 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on January 15, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.81 to $4.97 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on January 16, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.68 to $4.95 per share. The Reporting Person undertakes to provide to electroCore, Inc., any security holder of electroCore, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on January 17, 2019.
Chief Science & Strategy Officer
/s/ John L. Cleary, II, attorney-in-fact
2019-01-17